Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Research and Development

Human HealthOasmia is developing the next generation of drugs with focus on oncology.

Further reading »

About Oasmia

Animal HealthOasmia is a pharmaceutical company in Uppsala, Sweden with one approved product in Russia and one conditionally approved in the USA.

Further reading »

The Share

Latest News

Oasmia Pharmaceutical AB’s Warrant Programs Fully Subscribed

December 7 2016
Uppsala, Sweden, December 7, 2016 --- Oasmia Pharmaceutical (publ.) (”Oasmia” or ”The Company”) announces hereby that the previously announced warrant programs for the Oasmia management and Board of Directors are now fully subscribed.
Further reading »

Interim report for the period May - October 2016

December 2 2016
Expanded product portfolio and secured financing
Further reading »

Communiqué from Extraordinary General Meeting 2016

November 22 2016
Oasmia Pharmaceutical AB (publ.), with VAT no SE556332-667601, held on Monday, November 21, 2016, an Extraordinary General Meeting where the following main resolutions were made. For more detailed information about the content of the resolutions, see the notice for Extraordinary General Meeting which is available on Oasmia’s website www.oasmia.com.
Further reading »